Thursday, March 26, 2026
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Talking innovations in healthcare delivery with Dr. Brittany Busse

We speak with Dr. Brittany Busse and learn about her new startup, ViTel Health

Dr. Brittany Busse has over five years of experience in Executive Physician Leadership and in developing processes and technology specific for Telemedicine. As a physician leader, Dr. Busse is a vocal advocate for the well-being of both providers and patients. She has been a featured expert and contributor for a variety of local, regional and national media publications.

Her curiosity for innovation and technology and her excitement for improving the healthcare system is contagious. As the president and CMO of ViTelHealth, she is dedicated to improving healthcare delivery and organizing digital health tools that augment the patient-provider connection and improve outcomes so that everyone can thrive. When she is not promoting change in healthcare, she enjoys practicing and teaching yoga and meditation, creating gourmet plant-based meals for herself and her partner, and hiking in Northern California with her rescue dog, Cabernet.

To learn more about ViTel Health, please select the following link: https://www.vitelhealth.com/

#chronic #CCM #RPM #primary #care #innovations #myvitelhealth

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply

Your email address will not be published. Required fields are marked *

Videos

Policy Shift in Peptide Regulation

GLP-1 Drugs Have Moved Past Weight Loss. Medicine Has Not Fully Caught Up.

Glucagon-Like Peptide–Based Therapies and Longevity: Clinical Implications from Emerging Evidence

Glucagon-like peptide–based therapies are increasingly used for weight management and glycemic control, but their potential impact on long-term survival remains uncertain. The clinical question addressed in this report is whether treatment with glucagon-like peptide receptor agonists is associated with reductions in all-cause mortality and age-related morbidity beyond their established metabolic effects. This question matters because these agents are now prescribed across broad patient populations, including individuals without diabetes, and long-term exposure may influence cardiovascular, oncologic, and neurodegenerative outcomes. Understanding whether...

Read more

Join Our Newsletter!